The Bottom Line Although AOD-9604, MOTS-c, Tesamorelin, Semaglutide, and Tirzepatide are often discussed together, they serve very different purposes
Licensed Peptides products are developed using industry-standard synthesis and purification protocols, making them suitable for in vitro research, analytical testing, and experimental models
For patients seeing skin laxity alongside fat loss, this stack addresses both processes simultaneously
This compound is not intended for diagnostic, therapeutic, medical, or veterinary use under any circumstances
By targeting the NNMT enzyme, it may help enhance cellular energy, promote fat utilization, and support lean muscle retention